Evidence· June 29, 2026 · 19 min read
Topic
REMS
Risk Evaluation and Mitigation Strategies, restricted distribution, certification, monitoring, and access friction.
Policy· June 28, 2026 · 19 min read
How to Read an FDA REMS: ETASU, Shared vs. Single REMS, and the Patent Dance
By Ran Chen#REMS#Generics#FDA Approval
Generics· June 26, 2026 · 22 min read
Generic Revlimid REMS Launch: Lenalidomide ANDA Entry and NADAC Absence
By Ran Chen#Generics#Orange Book#Oncology
Biosimilars· June 21, 2026 · 6 min read
Soliris NMOSD Exclusivity Expiration: Skinny Label & REMS Barriers for Bkemv
Pricing & Access· May 27, 2026 · 10 min read
Spravato REMS and coverage guide for esketamine access
By Ran Chen#REMS#Prior Authorization#Coverage Access